EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 54 filers reported holding EDGE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $157,000 | – | 17,265 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,344,868 | $24,058,000 | 16.90% |
| VHCP Management II, LLC | 1,933,582 | $19,839,000 | 7.92% |
| ACUTA CAPITAL PARTNERS, LLC | 1,504,612 | $15,437,000 | 4.32% |
| Opaleye Management Inc. | 130,000 | $1,334,000 | 0.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $1,539,000 | 0.26% |
| DAFNA Capital Management LLC | 19,400 | $199,000 | 0.14% |
| REGENTATLANTIC CAPITAL LLC | 134,900 | $1,384,000 | 0.13% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 14,400 | $148,000 | 0.10% |
| TFS CAPITAL LLC | 20,080 | $206,000 | 0.08% |
| EAGLE ASSET MANAGEMENT INC | 901,359 | $9,247,000 | 0.06% |